Plain-English translation of NCT05204186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying how other health conditions (called comorbidities) affect recovery and survival in patients who have had bladder removal surgery for cancer. Researchers will use artificial intelligence and machine learning to analyze medical data from about 500 patients and build a predictive tool that can help doctors identify which patients are at higher risk of serious complications or death after surgery. The goal is to help doctors make better-informed decisions about treatment and care.
Currently, doctors sometimes make different decisions about bladder cancer treatment based on their personal judgment rather than clear evidence, which can lead to inconsistent care. By understanding how other health conditions influence surgical outcomes, this research aims to create better guidelines and tools to help doctors predict who will recover well and ensure all patients receive the most appropriate care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to review your medical records, surgical details, and follow-up health information to see how well you recovered after your bladder removal surgery. The study will track whether you experienced serious complications in the first 30 and 90 days after surgery, and will follow your overall health and survival over time. There are no additional visits or procedures required beyond your normal cancer follow-up care.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
France